JamesRobertVoelkerMD

Physician

Dr. Voelker is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
Lilly Corporate Ctr
Indianapolis, IN 46285
Phone+1 317-277-7590

Fax+1 317-433-6661

Indiana University School of MedicineFellowship, Clinical Pharmacology, 1986 - 1987
Indiana University School of MedicineClass of 1981

PubMed

9 citations
Pharmacokinetics and safety of single doses of tabalumab in subjects with rheumatoid arthritis or systemic lupus erythematosus
Jennifer Witcher, Roy Fleischmann, Vishala Chindalore, Ryan John Hansen, Leijun Hu
British Journal of Clinical Pharmacology. 2016-02-25
52 citations
A prospective study of multiple protein biomarkers to predict progression in diabetic chronic kidney disease
Rajiv Agarwal, Kevin L. Duffin, D. A. Laska, James Voelker, Matthew D. Breyer
Nephrology, Dialysis, Transplantation. 2014-12-01
8 citations
Pharmacokinetics of ruboxistaurin are significantly altered by rifampicin-mediated CYP3A4 induction.
Kwee Poo Yeo, Stephen L. Lowe, Ming Tung Lim, James Voelker, Jennifer L. Burkey
British Journal of Clinical Pharmacology. 2006-02-01

Effect Of Renal Dysfunction On The Pharmacokinetics Of EfegatranNational Center For Research Resources1996
Desmopressin In Normal Volunteers--Relationship Of ETS Current DensityNational Center For Research Resources1996
Captopril And Angiotensin Vascular Effects In SenescenceNational Center For Research Resources1995
Age Effects On Arterial Endothelium Derived Nitric Oxide Vasodilator SystemNational Center For Research Resources1995
Captopril And Angiotensin Vascular Effects In SenescenceNational Institute On Aging1991–1993